ARMO BioSciences (Series C)

Funding Details
Awarder
Inbox
Date Award
February 11, 2016
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$50,000,000

Company Info
Founding Year
2012
Traction
Demonstrated durable clinical responses in several types of cancer.
Founders
Peter Van Vlasselaer, PhD
Company Description
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.
Market
Oncology
Location
Redwood City, California, USA
Coinvestors
Celgene Corporation, Clough Capital Partners, DAG Ventures, GVHBM Healthcare Investments, Industrial Investors Group, NanoDimension, OrbiMed Advisors

Links